Cargando…
Effect of Endostar combined with chemotherapy in advanced well-differentiated pancreatic neuroendocrine tumors
The aim of the present study was to assess the effect of Endostar and temozolomide or dacarbazine plus 5-fluorouracil (5-FU) in patients with advanced pancreatic neuroendocrine tumors (pNETs). Phase II study of 14 patients with locally advanced or metastatic well-differentiated pNETs treated between...
Autores principales: | Cheng, Yue-Juan, Meng, Chang-Ting, Ying, Hong-Yan, Zhou, Jian-Feng, Yan, Xiao-Yan, Gao, Xin, Zhou, Na, Bai, Chun-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250533/ https://www.ncbi.nlm.nih.gov/pubmed/30407280 http://dx.doi.org/10.1097/MD.0000000000012750 |
Ejemplares similares
-
Endostar plus pembrolizumab combined with a platinum-based dual chemotherapy regime for advanced pulmonary large-cell neuroendocrine carcinoma as a first-line treatment: A case report
por: Zhang, Sijia, et al.
Publicado: (2022) -
Recombined humanized endostatin (Endostar) combined with chemotherapy for advanced bone and soft tissue sarcomas in stage IV
por: Xing, Peipei, et al.
Publicado: (2016) -
Endostar Combined with Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Nasopharyngeal Carcinoma: an Update
por: Jin, Ting, et al.
Publicado: (2018) -
Endostar, an Antiangiogenesis Inhibitor, Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer
por: Lu, Heming, et al.
Publicado: (2022) -
Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma
por: Wang, Yang, et al.
Publicado: (2018)